Tom Powles, Head of Solid Tumor Research at Barts Cancer Institute, shared on X:
“MOON-LANDING (CARE-2) is a European investigator initiated randomized phase II trial exploring Perioperative belzutifan/pembro vs adjuvant belzutifan/pembro.
A 3rd arm explores neoadjuvant triplet therapy. It’s due to start Q1 27 . to start, then and more we hope It’s also Spains entry into the Uromigos World Cup.”
Uromigos, added:
“Team Spain is shooting for the moon at the Uromigos World Cup!
From Barcelona, they’re discussing the Moonlanding trial, exploring new treatment combinations for kidney cancer.
Will La Roja take home the trophy?
The sky’s the limit!”
Proceed to the video attached to the post:
The Uromigos World Cup and Cancer Care
The Uromigos World Cup is an international educational and scientific competition organized by Uromigos, a group of genitourinary oncology experts dedicated to sharing balanced, evidence-based information about urological cancers.
The initiative brings together oncology teams from different countries to present short video discussions highlighting important clinical trials, emerging research, and advances in the treatment of kidney, bladder, and prostate cancers.
The initiative combines scientific education, international collaboration, and friendly competition to increase awareness of developments in genitourinary oncology.
You may also be interested in:
Tom Powles Highlights Brazil’s Contributions to Penile Cancer Research in Uromigos World Cup
Shilpa Gupta: Uromigos Calls for Support Ahead of the World Cup Competition
